8-ethinylxanthine Derivatives As Selective A2a Receptor Antagonists

Abstract

Disclosed are novel compounds of the general formula (Ia), and pharmaceutically acceptable salts, isomers, diastereomers or enantiomers thereof (Ia) and their use as medicines, for example in the treatment of dopamine-related movement disorders.


Claims

Sign in to the Lens